160 related articles for article (PubMed ID: 35490543)
21. The impact of estimation methods for alcohol-attributable mortality on long-term trends for the general population and by educational level in Finland and Italy (Turin).
Van Hemelrijck WMJ; Martikainen P; Zengarini N; Costa G; Janssen F
PLoS One; 2023; 18(12):e0295760. PubMed ID: 38096271
[TBL] [Abstract][Full Text] [Related]
22. Different approaches to the analysis of causes of death during the COVID-19 epidemic.
Fedeli U; Schievano E; Avossa F; Pitter G; Barbiellini Amidei C; Grande E; Grippo F
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3610-3613. PubMed ID: 34002836
[TBL] [Abstract][Full Text] [Related]
23. Estimating Overall and Cause-Specific Excess Mortality during the COVID-19 Pandemic: Methodological Approaches Compared.
Barbiellini Amidei C; Fedeli U; Gennaro N; Cestari L; Schievano E; Zorzi M; Girardi P; Casotto V
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297545
[TBL] [Abstract][Full Text] [Related]
24. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
Mylne AQ; Griffiths C; Rooney C; Doyle P
Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
[TBL] [Abstract][Full Text] [Related]
25. Trends in parkinson's disease mortality in China from 2004 to 2021: a joinpoint analysis.
Wang S; Jiang S; Wu J; Miao Y; Duan Y; Mu Z; Wang J; Tang Y; Su M; Guo Z; Yu X; Zhao Y
BMC Public Health; 2024 Apr; 24(1):1091. PubMed ID: 38641581
[TBL] [Abstract][Full Text] [Related]
26. Changes in cancer-related mortality during the COVID-19 pandemic in the United States.
Fedeli U; Barbiellini Amidei C; Han X; Jemal A
J Natl Cancer Inst; 2024 Jan; 116(1):167-169. PubMed ID: 37688577
[TBL] [Abstract][Full Text] [Related]
27. Mortality Associated with Idiopathic Pulmonary Fibrosis in Northeastern Italy, 2008-2020: A Multiple Cause of Death Analysis.
Marcon A; Schievano E; Fedeli U
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299699
[TBL] [Abstract][Full Text] [Related]
28. Excess deaths from Alzheimer's disease and Parkinson's disease during the COVID-19 pandemic in the USA.
Li S; Han L; Shi H; Chong MKC; Zhao S; Ran J
Age Ageing; 2022 Dec; 51(12):. PubMed ID: 36571781
[TBL] [Abstract][Full Text] [Related]
29. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P; Meara J
BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
[TBL] [Abstract][Full Text] [Related]
30. Mortality rate related to peripheral arterial disease: A retrospective analysis of epidemiological data (years 2008-2019).
Voci D; Fedeli U; Valerio L; Schievano E; Righini M; Kucher N; Spirk D; Barco S
Nutr Metab Cardiovasc Dis; 2023 Mar; 33(3):516-522. PubMed ID: 36642604
[TBL] [Abstract][Full Text] [Related]
31. COPD-Related Mortality before and after Mass COVID-19 Vaccination in Northern Italy.
Fedeli U; Casotto V; Barbiellini Amidei C; Vianello A; Guarnieri G
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631960
[TBL] [Abstract][Full Text] [Related]
32. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.
Sheu MJ; Liang FW; Lin CY; Lu TH
Popul Health Metr; 2021 Apr; 19(1):22. PubMed ID: 33926463
[TBL] [Abstract][Full Text] [Related]
33. Increasing epilepsy-related mortality: A multiple causes of death study in Northern Italy.
Casotto V; Ranzato F; Girardi P; Fedeli U
Seizure; 2022 Jan; 94():1-6. PubMed ID: 34801832
[TBL] [Abstract][Full Text] [Related]
34. How can the national burden of Parkinson's disease comorbidity and mortality be estimated for the Japanese population?
Doi Y; Yokoyama T; Nakamura Y; Nagai M; Fujimoto K; Nakano I
J Epidemiol; 2011; 21(3):211-6. PubMed ID: 21422700
[TBL] [Abstract][Full Text] [Related]
35. Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.
Fairman KA; Goodlet KJ; Rucker JD; Zawadzki RS
BMJ Open; 2021 Nov; 11(11):e050361. PubMed ID: 34785551
[TBL] [Abstract][Full Text] [Related]
36. Association of multiple-sclerosis-related mortality with COVID-19 and other common infections: a multiple causes of death analysis.
Fedeli U; Barbiellini Amidei C; Avossa F; Schievano E; Kingwell E
Eur J Neurol; 2023 Sep; 30(9):2870-2873. PubMed ID: 37306563
[TBL] [Abstract][Full Text] [Related]
37. Determining stroke's rank as a cause of death using multicause mortality data.
Burke JF; Lisabeth LD; Brown DL; Reeves MJ; Morgenstern LB
Stroke; 2012 Aug; 43(8):2207-11. PubMed ID: 22821613
[TBL] [Abstract][Full Text] [Related]
38. Comparison of official coders versus physician panel in assignment of underlying cause of death.
Lu TH; Chang HY; Hwu CM; Chiu HC; Yin WH; Pan WH
J Formos Med Assoc; 2001 Jun; 100(6):365-9. PubMed ID: 11480244
[TBL] [Abstract][Full Text] [Related]
39. Excess mortality related to circulatory system diseases and diabetes mellitus among Italian AIDS patients vs. non-AIDS population: a population-based cohort study using the multiple causes-of-death approach.
Suligoi B; Virdone S; Taborelli M; Frova L; Grande E; Grippo F; Pappagallo M; Regine V; Pugliese L; Serraino D; Zucchetto A
BMC Infect Dis; 2018 Aug; 18(1):428. PubMed ID: 30153797
[TBL] [Abstract][Full Text] [Related]
40. The role of overweight and obesity in adverse cardiovascular disease mortality trends: an analysis of multiple cause of death data from Australia and the USA.
Adair T; Lopez AD
BMC Med; 2020 Aug; 18(1):199. PubMed ID: 32746822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
